Website profiles · Technology insights · Alternatives

empowermentqe.com

Technical GxP IT audits that go beyond documentation. Computerised System Validation, supplier and cloud audits, AI/ML validation and EU GMP Annex 11 / Annex 22 readiness. 300+ global audits. Based in Northern Ireland, working worldwide.

No paid content found
Visit website
Profile views 10 Outbound visits 14 Normal
GxP IT Audit, CSV & AI/ML Validation Consultancy | Empowerment Quality Engineering Full homepage screenshot

At a glance

Category
Artificial Intelligence
Language
English
Paid-content signal
No paid content foundObserved
Registered
2007
Hosting
CloudflareInferred
HTTPS certificate trusted
PassedObserved
Last updated

Website review

This review may include AI-generated content and is not individually verified. Domain, certificate and other facts come from the observed data on this page.

What is Empowerment Quality Engineering?

Empowerment Quality Engineering is a consultancy that sits between regulatory quality and IT in the pharma and life sciences sector. Its focus is GxP compliance for computerised systems — including CSV (Computerised System Validation), IT audits, supplier and cloud audits, and AI/ML validation — with readiness support for EU GMP Annex 11 and Annex 22. Based in Northern Ireland, it works worldwide and states it has completed 300+ global computerised system audits and been practising since 1997.

Who it serves

  • Pharma and life sciences organisations: help engaging suppliers, understanding technical jargon in plain language, spotting regulatory and operational gaps, and estimating total cost of vendor ownership.
  • IT suppliers to pharma: explaining why customers make particular compliance demands and how to meet them efficiently, positioning the supplier as a stronger partner.
  • AI/ML system owners: validating, auditing and governing AI-driven systems to GxP standards, aligned to the EU AI Act, FDA AI/ML-based SaMD guidance and ISO 42001.

What it actually does

Its six core service areas include quality management systems work, computer system audits, supplier and GDPR assessments, and AI/ML system work. The stated outcomes are protecting patient health, improving compliance, reducing costs and defects, and reducing rework and delays.

Where it differs from a documentation-only auditor

The site emphasises a technical, engineering-led approach: staff who have analysed, coded, tested, installed and decommissioned complex systems, rather than only reviewing paperwork. It also notes formal AI training at Oxford Saïd Business School, which supports the AI/ML governance side of the offering.

A practical next step

If you are a pharma company evaluating a vendor, ask for evidence of audits in your specific system category — for example, cloud-hosted clinical or manufacturing systems — and request a scoping call before committing to a full audit. If you are a supplier, ask for a review of your own software lifecycle (SLC) process; that is the entry point the consultancy itself offers. For AI/ML, check whether your intended use falls under medical device software rules, since that changes the applicable guidance.

For broader context on GxP and validation expectations, the official regulators are the best starting points: U.S. Food and Drug Administration and European Medicines Agency.

How do I prepare for an EU GMP Annex 11 or Annex 22 inspection?

Start by separating what Annex 11 and Annex 22 actually require, because they are not the same inspection. Annex 11 is about computerised systems used in GxP environments: validation, security, data integrity, supplier management, change control, incident management and business continuity. Annex 22 is the newer, narrower topic of AI/ML in GxP, including model governance, data provenance, performance monitoring and human oversight. An inspection preparation plan should cover both only if you use AI/ML in a regulated activity.

A practical preparation sequence

  1. Define scope and system inventory. List every computerised system and AI/ML model that touches GxP data, products, release decisions or patient safety. Include cloud services, spreadsheets, LIMS, ERP, eQMS, analytics and any supplier-hosted tool. For each, record the regulated activity it supports, the data it handles and its GxP relevance.
  2. Map Annex 11 expectations to evidence. For each system, assemble validation documentation, risk assessments, user requirements, test evidence, traceability, access controls, audit trails, data integrity controls, change records, periodic review reports, incident logs, backup/restore tests and supplier agreements.
  3. Map Annex 22 expectations where AI/ML applies. Prepare model descriptions, training and validation data provenance, performance metrics, validation approach, bias and drift monitoring, version control, retraining triggers, human oversight and escalation, plus how outputs are used in decisions.
  4. Prepare supplier and cloud evidence. Inspectors often ask how you assure third parties. Have service-level agreements, audit reports, qualification evidence, data-processing terms, GDPR roles and cloud provider assurance available.
  5. Run a mock inspection. Walk through the data lifecycle from creation to archive for two or three high-risk systems. Ask whether an inspector could reconstruct who did what, when, why and with which version.
  6. Fix gaps before the inspection. Prioritise patient-safety and data-integrity gaps. Document remediation plans, owners and dates. An open, credible CAPA is usually stronger than an undocumented gap.
  7. Brief the people who will speak. Quality, IT, validation, data owners and supplier contacts should know their scope and the evidence they own. Rehearse plain-language explanations of technical controls.
  8. Prepare the inspection room. Have an index of systems, documents, logs and named contacts. Provide read-only access to relevant systems where possible rather than live demonstrations under pressure.

How the two areas differ

Area Annex 11 focus Annex 22 / AI/ML focus
Core question Is the computerised system validated, secure and controlled? Is the AI/ML model fit for purpose, governed and monitored?
Key evidence Validation, audit trails, access control, change control, supplier oversight Data provenance, model validation, performance monitoring, drift, human oversight
Main risk Data integrity, unauthorised changes, supplier dependency Unvalidated outputs, bias, model drift, unclear accountability
Inspection style System and lifecycle documentation Model lifecycle and decision-use documentation

A concrete reader scenario

A small pharma company uses a cloud eQMS and a machine-learning tool to flag deviations. For Annex 11, the team should be able to show the eQMS validation package, audit trails, access reviews, change history, backup tests and the supplier agreement. For Annex 22, they should explain how the model was trained, what data it uses, how its performance is monitored, who reviews flagged deviations and what happens when the model is wrong. If the company cannot answer the last two questions, that is the gap to close first.

Next step

Run a one-day self-assessment against both annexes for your highest-risk system or model. Score each expectation as evidenced, partially evidenced or missing, then assign owners and dates. If you need a structured starting point, consult the consultancy's published audit depth model and Annex 11/22 readiness material at Empowerment Quality Engineering, and compare your approach with official regulator guidance before finalising your plan.

What should a pharma company check in a supplier or cloud audit before signing a contract?

For a pharma company, a supplier or cloud audit before signing is less about checking a certificate and more about proving the supplier can keep your GxP data intact, your validation defensible and your patients safe. Empowerment Quality Engineering frames this as the grey area between Regulatory Quality and IT, and its audit approach is technical rather than documentation-only. That distinction matters: a supplier can hold ISO 27001 and still fail an Annex 11 inspection because its change control, audit trails or backup restores are not fit for GxP use.

What to verify before signing

  • Data integrity and audit trails. Can the supplier produce complete, computer-generated, time-stamped audit trails for your data? Who can edit or disable them? Are records retained for your required period, and can you export them in a usable format if you leave?
  • Validation status and documentation. Ask for the supplier's own validation package: intended use, risk assessment, test evidence, traceability and deviation records. Check whether it covers your specific configuration, not just the base product.
  • Change and release control. How much notice do you get before a release? Can changes occur without your approval? What happens to your validation status after an upgrade?
  • Access, segregation and security. How are your data separated from other tenants? How is privileged access granted, reviewed and revoked? How are breaches detected and notified to you?
  • Subcontractors and data location. Which fourth parties touch your data, in which countries, and under what contractual and audit rights? This is where many cloud audits reveal gaps.
  • Business continuity and exit. Tested restore evidence, recovery time and recovery point objectives, and a credible exit plan with data return and deletion.
  • Quality agreement and audit rights. A written quality agreement, defined responsibilities, notification duties and the right to audit — including for cause — before you are locked in.

A practical comparison

Area Documentation-only audit Technical audit
Audit trails Confirms a procedure exists Tests whether trails are complete and tamper-evident
Validation Reviews a certificate Reviews intended use, risk and test evidence for your use
Cloud controls Checks policy statements Examines access, segregation, backup and restore evidence
Exit Assumes data return Verifies export format, retention and deletion

Next step

Before the audit, write a one-page intended-use and data-flow description for the service, then ask the supplier for the evidence list above in advance. If they cannot supply audit trail, restore and fourth-party details, treat that as a finding rather than a paperwork delay. Empowerment Quality Engineering's own materials describe 300+ global computerised system audits and a free consultation route, which suits companies that want a technical opinion before committing. For general supplier assurance context, see ISPE and PIC/S.

How do I validate an AI/ML system for GxP use under the EU AI Act and FDA guidance?

Validation for GxP AI/ML is not a single test but a lifecycle argument: define intended use, assess risk, control data and model change, and keep evidence that the system stays fit for purpose.

Start with the answer

Build a computerised system validation (CSV) approach around the AI/ML model, then layer on AI-specific governance. In practice that means:

  • Write a clear intended-use and risk statement, including whether the output influences patient safety, product quality or regulatory decisions.
  • Classify the system under your GxP risk framework and map it to the relevant EU AI Act risk category and FDA expectations for the specific use (for example, AI/ML-based Software as a Medical Device versus an internal quality decision-support tool).
  • Produce a validation plan covering data provenance, model development, training and test data, performance metrics, human oversight, and change control.
  • Treat the model as a living component: define retraining triggers, version control, drift monitoring and revalidation criteria.
  • Keep supplier and cloud evidence under control, since many AI/ML systems are hosted or embedded in vendor platforms.

Where the frameworks differ

Area EU AI Act focus FDA guidance focus
Primary lens Risk category and obligations on providers/deployers Device or drug/GxP context, including SaMD
Documentation Technical documentation, risk management, transparency Predetermined change control plans, validation evidence
Ongoing duties Post-market monitoring, incident reporting Lifecycle maintenance, performance monitoring
Practical overlap Both expect traceability, human oversight and documented change control Both expect traceability, human oversight and documented change control

Use the overlap as your core validation package, then add the jurisdiction-specific documentation.

A concrete reader scenario

A pharma quality team wants to deploy a vendor-hosted model that flags batch deviations. The validation lead should ask: what decision does the output drive, who reviews it, what happens when the model is wrong, and how will retraining be approved? If the model only prioritises records for human review, the risk is lower than if it automatically releases or rejects batches. That distinction drives the depth of testing, the oversight controls and the revalidation triggers.

Next step

Draft a one-page intended-use and risk statement before writing any test scripts. If you need a benchmark for audit depth and AI/ML governance, Empowerment Quality Engineering describes GxP IT audit, CSV and AI/ML validation services. For official regulatory text, check the FDA and the EU AI Act directly.

What is the true cost of ownership when engaging a GxP software vendor?

True cost of ownership (TCO) for a GxP software vendor is the purchase price plus everything needed to keep the system compliant, validated and usable across its whole life. Licence fees are usually the smallest part; validation effort, audit responses, change control, supplier oversight, training and eventual decommissioning dominate. Empowerment Quality Engineering's page frames this directly: it offers to "define the total cost of (vendor) ownership" for pharma organisations and says it has completed 300+ global computerised system audits, so its angle is audit-informed cost visibility rather than software pricing.

The cost buckets that matter

  • Acquisition: licence/subscription, implementation, configuration, data migration, interfaces to LIMS, ERP, eQMS or instruments.
  • Validation: GxP-relevant risk assessment, requirements, IQ/OQ/PQ or equivalent, traceability, test scripts, review and approval, plus periodic review. This is often underestimated because it consumes scarce QA and SME time.
  • Supplier qualification and oversight: audits, quality agreements, questionnaires, security and GDPR assessments, and re-assessment after changes. The page lists supplier and GDPR assessments and supplier/cloud audits as services, reflecting how much of TCO sits in managing the vendor.
  • Change control and revalidation: every vendor upgrade, patch, cloud change or AI/ML model update can trigger impact assessment and re-testing.
  • Operations: admin, user management, training, support tickets, downtime, workarounds and data integrity remediation.
  • Exit: data extraction, retention, decommissioning and record archiving.

A quick way to compare options

Cost driver Typical pattern What it does to TCO
Validation Heavier for configurable/custom systems Front-loaded but recurring at each change
Supplier documentation Strong QMS/documentation reduces effort Lower audit and remediation cost
Cloud vs on-premise Cloud shifts cost to subscription and vendor oversight Lower infrastructure, higher dependency risk
AI/ML components Model change and drift need ongoing governance Adds recurring validation and monitoring
Exit and data Poor export or lock-in raises switching cost Inflates lifetime cost

Practical next step

Build a five-year model with your own internal day rates, then ask each vendor for validation deliverables, change-notification commitments, audit support and data-export terms. For supplier-side readers, the page's "Request a SLC Process Review" is aimed at showing why customers ask for what they ask for — useful if you want to reduce the cost your own customers impose on you. For broader regulatory context, see U.S. Food and Drug Administration and European Medicines Agency.

How can an IT supplier meet pharma customers' GxP and CSV requirements at low cost?

An IT supplier meets pharma GxP and CSV expectations most cheaply by treating compliance as a product feature rather than a per-customer project: build one reusable validation and audit evidence set, then tailor the customer-facing summary to each buyer.

Where the cost actually sits

Most supplier cost comes from re-doing the same work for every pharma customer: repeated questionnaires, one-off validation documents, ad-hoc audit responses, and late scrambles when a customer's quality team asks for something the product was never designed to capture. Empowerment Quality Engineering's page frames this from the supplier side — it says it shows suppliers "exactly why your customers ask for what they ask for, and how to meet those needs efficiently and at low cost." That is the right goal, but the mechanism is yours to build.

A low-cost operating model

  • Keep a single controlled document set (validation plan, risk assessment, test evidence, traceability, change control, SOPs) and issue customer-specific extracts rather than new documents.
  • Maintain a standing supplier-questionnaire answer library mapped to common frameworks, so responses are consistent and fast.
  • Design audit trails, access control, e-signatures and data integrity into the product; retrofitting them under customer pressure is where budgets break.
  • Track regulatory change once, centrally, instead of per contract.
  • Rehearse a mock audit internally so real customer audits are confirmations, not discoveries.

Trade-offs to decide deliberately

Approach Upfront cost Per-customer cost Best when
Bespoke validation per client Low High One large strategic customer
Reusable core + tailored extracts Medium Low Multiple pharma customers
Full pre-certified package High Lowest Regulated SaaS at scale

Practical next step

Before your next pharma contract, list every quality artefact that customer asked for in the last two deals. Anything requested twice belongs in your reusable core. For AI/ML features, apply the same discipline: the page notes alignment to the EU AI Act, FDA AI/ML SaMD guidance and ISO 42001, so governance documentation should be designed in from the start rather than assembled during procurement.

If you want an outside read on where your evidence set is thin, Empowerment Quality Engineering offers a supplier-focused process review alongside its audit work.

Related questions

More questions →
What is empowermentqe.com?
Technical GxP IT audits that go beyond documentation. Computerised System Validation, supplier and cloud audits, AI/ML validation and EU GMP Annex 11 / Annex 22 readiness. 300+ global audits. Based in Northern Ireland, working worldwide.
Does empowermentqe.com offer paid content?
Unknown.
What languages does empowermentqe.com support?
Primary language: English.
How can I visit empowermentqe.com?
Use the Visit website link to open the website in a new tab.
What are some alternatives to empowermentqe.com?
Related websites include zoominfo.com, zooi.ai, zeroheight.com, zenml.io, zenmic.com, zebracat.ai. Compare their features and pricing for your needs.

Website Overview

An established domain and managed infrastructure suggest continuity of operations and may support dependable delivery, although neither guarantees service quality. Several search or sharing settings need attention. Together they may make snippets, preview images or preferred URLs less consistent across platforms.

Domain and Registration

Registered in 2007, this domain has about 19 years of history. That suggests continuity, although ownership and purpose may have changed. Transfer-protection status is present, helping reduce the risk of unauthorized domain transfers. The domain uses the common .com extension, which is not an independent safety signal.

DNS and Email

The observed email authentication setup is incomplete: DMARC is missing. Nameservers are provided by ui-dns.biz, indicating managed DNS hosting. DNS and provider evidence indicate traffic passes through the Cloudflare CDN, which may support caching and traffic distribution. MX records point to the Microsoft 365 email service. DNSSEC signatures were not detected, so this additional DNS authenticity protection is not confirmed.

TLS and Certificates

The public key uses EC with 256 bits. The server supplied a complete certificate chain. No organization name is present in the certificate; the available fields are consistent with domain validation. The certificate was issued within the Google Trust Services cloud or CDN ecosystem. The certificate's total validity is about 90 days, consistent with a short renewal cycle.

HTTP and Browser Security

No X-Powered-By header was found, reducing one common source of backend fingerprinting information. All six checked browser-security headers are present. Their effectiveness still depends on the policy values and application behavior. The cf-ray response header indicates a CDN or caching proxy in the delivery path. No obvious internal addresses or debug information were found in the headers. The Server header identifies cloudflare without an exact version.

Technology Stack Analysis

The public page identifies Bootstrap, Cloudflare without precise versions, leaving fewer clues for version-specific scanning.

Search and Social Sharing

The title has 82 characters and may be truncated in search results. The meta description has 237 characters and may be shortened in search results. Twitter Card metadata is configured. JSON-LD includes Organization data, helping describe the organization as an entity. The observed directives allow indexing and link following.

Hosting and Email

DNSui-dns.biz
HostingCloudflare
EmailMicrosoft 365
Approximate IP geolocation (inferred; a CDN or proxy may differ from the origin server) Location unknown Inferred 104.21.60.131

Registration details

RDAP / WHOIS

RegistrarIONOS SE
Registered2007-01-06
Expires2027-01-06
Domain statusclient transfer prohibited
Nameserversns1109.ui-dns.biz、ns1109.ui-dns.com、ns1109.ui-dns.de、ns1109.ui-dns.org
DNSSECunsigned

DNS records

DNS

TypeNameValueTTLPriority
Awww.empowermentqe.com.cdn.cloudflare.net104.21.60.131300—
Awww.empowermentqe.com.cdn.cloudflare.net172.67.196.216300—
AAAAwww.empowermentqe.com.cdn.cloudflare.net2606:4700:3035::6815:3c83300—
AAAAwww.empowermentqe.com.cdn.cloudflare.net2606:4700:3036::ac43:c4d8300—
MXempowermentqe.comempowermentqe-com.mail.protection.outlook.com360010
MXempowermentqe.commx00.1and1.co.uk360020
MXempowermentqe.commx01.1and1.co.uk360021
NSempowermentqe.comns1109.ui-dns.biz172800—
NSempowermentqe.comns1109.ui-dns.com172800—
NSempowermentqe.comns1109.ui-dns.de172800—
NSempowermentqe.comns1109.ui-dns.org172800—
TXTempowermentqe.comv=spf1 include:spf.protection.outlook.com -all3600—
CNAMEwww.empowermentqe.comwww.empowermentqe.com.cdn.cloudflare.net3600—

TLS and certificates

TLS / SSL

AssessmentNormal configuration
Supported protocolsTLSv1.2、TLSv1.3
Negotiated protocolTLSv1.3
Certificate subjectwww.empowermentqe.com
IssuerGoogle Trust Services
Valid until2026-11-14T10:40 · Remaining when checked: 44 days
Verification detailsCertificate trust: Passed · Hostname match: Passed

HTTP response headers

HTTP

HeaderValue
content-typetext/html
cache-controlno-cache, must-revalidate
servercloudflare
strict-transport-securitymax-age=31536000; includeSubDomains
content-security-policydefault-src 'self'; script-src 'self' 'unsafe-inline' https://code.jquery.com https://cdn.jsdelivr.net https://cdnjs.cloudflare.com; style-src 'self' 'unsafe-inline' https://fonts.googleapis.com https://cdn.jsdelivr.net https://cdnjs.cloudflare.com; font-src 'self' https://fonts.gstatic.com https://cdnjs.cloudflare.com; img-src 'self' data:; form-action https://formspree.io; connect-src 'self' https://formspree.io; frame-ancestors 'none'; base-uri 'self'; upgrade-insecure-requests
x-frame-optionsSAMEORIGIN
x-content-type-optionsnosniff
referrer-policystrict-origin-when-cross-origin
permissions-policygeolocation=(), microphone=(), camera=(), payment=()

Identified technologies

BootstrapCloudflare

Pages, Search and Sharing

Meta descriptionTechnical GxP IT audits that go beyond documentation. Computerised System Validation, supplier and cloud audits, AI/ML validation and EU GMP Annex 11 / Annex 22 readiness. 300+ global audits. Based in Northern Ireland, working worldwide.
Canonical URLhttps://www.empowermentqe.com/
LanguageEnglish (default)
Twitter Cardsummary_large_image
All bots 1 allowed · 0 disallowed
  • Allow/
gptbot 1 allowed · 0 disallowed
  • Allow/
chatgpt-user 1 allowed · 0 disallowed
  • Allow/
claudebot 1 allowed · 0 disallowed
  • Allow/
claude-web 1 allowed · 0 disallowed
  • Allow/
perplexitybot 1 allowed · 0 disallowed
  • Allow/
google-extended 1 allowed · 0 disallowed
  • Allow/
applebot-extended 1 allowed · 0 disallowed
  • Allow/

User reviews (0)

  • No reviews yet.